Dr. Aditi Mehta
| Dr. Aditi Mehta (Postdoc)
|
Since September 2020 Senior Manager Drug Delivery, Merck KGaA November 2017 - August 2020 Group Leader, LMU Munich |
| Publications: |
A Method for Targeted Nonviral siRNA Delivery in Cancer and Inflammatory Diseases. Kandil R, Xie Y, Mehta A, Merkel O. Aditi Mehta, Olivia M. Merkel*: Immunogenicity of Cas9 Protein. Coming in and Finding Out: Blending Receptor-Targeted Delivery and Efficient Endosomal Escape in a Novel Bio-Responsive siRNA Delivery System for Gene Knockdown in Pulmonary T Cells. Kandil R, Xie Y, Heermann R, Isert L, Jung K, Mehta A, Merkel OM. Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles. Mehta A, Dalle Vedove E, Isert L, Merkel OM. Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis. Rubio K, Singh I, Dobersch S, Sarvari P, Günther S, Cordero J, Mehta A, Wujak L, Cabrera-Fuentes H, Chao CM, Braubach P, Bellusci S, Seeger W, Günther A, Preissner KT, Wygrecka M, Savai R, Papy-Garcia D, Dobreva G, Heikenwalder M, Savai-Pullamsetti S, Braun T, Barreto G. CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review. Babačić H, Mehta A, Merkel O, Schoser B. MiCEE is a ncRNA-protein complex that mediates epigenetic silencing and nucleolar organization. Singh I, Contreras A, Cordero J, Rubio K, Dobersch S, Günther S, Jeratsch S, Mehta A, Krüger M, Graumann J, Seeger W, Dobreva G, Braun T and Barreto G. MiCEE is a ncRNA-protein complex that mediates epigenetic silencing and nucleolus organization. Non-invasive approaches for lung cancer diagnosis. Mehta A, Barreto G. Non-invasive lung cancer diagnosis by detection of GATA6 and NKX2-1 isoforms in exhaled breath condensate., Mehta A, Cordero J, Dobersch S, Romero-Olmedo AJ, Savai R, Bodner J, Chao CM, Fink L, Guzmán-Díaz E, Singh I, Dobreva G, Rapp UR, Günther S, Ilinskaya ON, Bellusci S, Dammann RH, Braun T, Seeger W, Gattenlöhner S, Tresch A, Günther A, Barreto G., EMBO Mol Med. 2016; 8 (12):1380-1389. High mobility group protein-mediated transcription requires DNA damage marker γ-H2AX., Singh I, Ozturk N, Cordero J, Mehta A, Hasan D, Cosentino C, Sebastian C, Krüger M, Looso M, Carraro G, Bellusci S, Seeger W, Braun T, Mostoslavsky R, Barreto G., Cell Res. 2015; 25 (7):837-50. Epigenetics in lung cancer diagnosis and therapy., Mehta A, Dobersch S, Romero-Olmedo AJ, Barreto G., Cancer Metastasis Rev. 2015; 34 (2):229-41. Validation of Tuba1a as appropriate internal control for normalization of gene expression analysis during mouse lung development., Mehta A, Dobersch S, Dammann RH, Bellusci S, Ilinskaya ON, Braun T, Barreto G., Int J Mol Sci. 2015; 16 (3):4492-511 HMGA proteins as modulators of chromatin structure during transcriptional activation., Ozturk N, Singh I, Mehta A, Braun T, Barreto G., Front Cell Dev Biol. 2014; 2:5. Hmga2 is required for canonical WNT signaling during lung development., Singh I, Mehta A, Contreras A, Boettger T, Carraro G, Wheeler M, Cabrera-Fuentes HA, Bellusci S, Seeger W, Braun T, Barreto G., BMC Biol. 2014; 12:21. Quantitative proteome analysis of alveolar type-II cells reveals a connection of integrin receptor subunits beta 2/6 and WNT signaling., Mukhametshina RT, Ruhs A, Singh I, Hasan D, Contreras A, Mehta A, Nikam VS, Ahlbrecht K, Carraro G, Cabrera-Fuentes HA, Jiang D, Voswinckel R, Seeger W, Bellusci S, Scharffetter-Kochanek K, Bagaeva TV, Preissner KT, Boettger T, Braun T, Krüger M, Barreto G., J Proteome Res. 2013; 12 (12):5598-608. |
